RANDOMIZED PLACEBO-CONTROLLED PHASE II TRIAL OF PERIFOSINE PLUS CAPECITABINE AS SECOND- OR THIRD-LINE THERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER

Tuesday, July 26, 2011